Contact
searchSearch
HMP Global

Advertisement

Advertisement

ADVERTISEMENT

Acute Myeloid Leukemia Topic Center

Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie
Interview
Reviewing the Benefits of a Treatment for Patients With Acute Myeloid Leukemia
08/09/2021
Julie Gould
Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie, discusses recent study findings presented at ASCO 2021, highlighting the efficacy of venetoclax for the treatment of acute myeloid leukemia.
Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie, discusses recent study findings presented at ASCO 2021, highlighting the efficacy of venetoclax for the treatment of acute myeloid leukemia.
Michael Werner, PhD, scientific...
08/09/2021
Population Health
From Population Health
News
New Guidelines Address for Care of Older Adults With AML
08/12/2020
The American Society of Hematology released new guidelines for treating older adults with acute myeloid leukemia, and recommends chemotherapy or other treatments over supportive care, along with more intensive therapy over less-intensive...
The American Society of Hematology released new guidelines for treating older adults with acute myeloid leukemia, and recommends chemotherapy or other treatments over supportive care, along with more intensive therapy over less-intensive...
The American Society of...
08/12/2020
First Report Managed Care
News
Substantial Economic Burden Accompanies Various AML Treatments
07/14/2020
“As data for this analysis were collected before approval for these new therapies, this study serves as a baseline for the clinical and economic burden associated with AML, allowing for comparisons related to the cost-benefit of emerging...
“As data for this analysis were collected before approval for these new therapies, this study serves as a baseline for the clinical and economic burden associated with AML, allowing for comparisons related to the cost-benefit of emerging...
“As data for this analysis were...
07/14/2020
First Report Managed Care
News
Palliative Care Proves Beneficial in Treatment of Patients With AML
06/03/2020
Patients with acute myeloid leukemia saw improvements in their quality of life when palliative care was integrated with their oncology treatment, according to recent data.
Patients with acute myeloid leukemia saw improvements in their quality of life when palliative care was integrated with their oncology treatment, according to recent data.
Patients with acute myeloid...
06/03/2020
First Report Managed Care
News
Examining Health Care Utilization, Clinical Burden of AML for Payers
05/07/2020
As the incidence rate of patients with AML in the US continues to rise, researchers of a recent study conducted an analysis of the economical and clinical burden of treatment for commercial payers.
As the incidence rate of patients with AML in the US continues to rise, researchers of a recent study conducted an analysis of the economical and clinical burden of treatment for commercial payers.
As the incidence rate of...
05/07/2020
First Report Managed Care
News
Myeloablative Conditioning Improves Survival Among Patients With AML
03/05/2020
Researchers recently found that myeloablative conditioning improved survival among patients with acute myeloid leukemia rather than reduced-intensity conditioning.
Researchers recently found that myeloablative conditioning improved survival among patients with acute myeloid leukemia rather than reduced-intensity conditioning.
Researchers recently found that...
03/05/2020
First Report Managed Care
News
Acute Myocardial Infarction Outcomes Worse in Patients With AML
01/31/2020
Compared with other patients, patients with leukemia were less likely to be offered coronary angiography and percutaneous coronary intervention following acute myocardial infarction, according to the study.
Compared with other patients, patients with leukemia were less likely to be offered coronary angiography and percutaneous coronary intervention following acute myocardial infarction, according to the study.
Compared with other patients,...
01/31/2020
First Report Managed Care
News
Lower Costs, Improved Survival Linked With Nonmyeloablative Conditioning for AML
01/15/2020
Nonmyeloablative conditioning was associated with lower reimbursement and improved overall survival 1 year after allogeneic hematopoietic cell transplantation in a group of older adults with acute myeloid leukemia, according to study findings.
Nonmyeloablative conditioning was associated with lower reimbursement and improved overall survival 1 year after allogeneic hematopoietic cell transplantation in a group of older adults with acute myeloid leukemia, according to study findings.
Nonmyeloablative conditioning...
01/15/2020
First Report Managed Care
Formulary Frontlines®
Exploring Treatment for Acute Myeloid Leukemia
06/18/2019

Edan Stanley

Edan Stanley
AML is the most common acute leukemia in adults with an estimated 21,450 new cases expected in 2019 in the United States and approximately 10,920 deaths. In this segment, we explore various treatments for AML.
AML is the most common acute leukemia in adults with an estimated 21,450 new cases expected in 2019 in the United States and approximately 10,920 deaths. In this segment, we explore various treatments for AML.
AML is the most common acute...
06/18/2019
First Report Managed Care
Formulary Frontlines®
Breakthroughs in Acute Myeloid Leukemia
10/26/2017

S Russell Spjut, PharmD, clinical pharmacist of formulary management at MagellanRx Management

S Russell Spjut, PharmD, clinical pha...
S Russell Spjut, PharmD, discusses current first-line therapies and new treatment opions used to treat acute myeloid leukemia and their associated costs. 
S Russell Spjut, PharmD, discusses current first-line therapies and new treatment opions used to treat acute myeloid leukemia and their associated costs. 
S Russell Spjut, PharmD,...
10/26/2017
First Report Managed Care
News
Integrated Genetic Profiling in Acute Myeloid Leukemia
07/23/2012

Kevin L. Carter

Kevin L. Carter
A series of somatic mutations that affect the progression and development of acute myeloid leukemia (AML) has recently been discovered. The prognostic relevance of cytogenetic abnormalities has led to the widespread adoption of risk...
A series of somatic mutations that affect the progression and development of acute myeloid leukemia (AML) has recently been discovered. The prognostic relevance of cytogenetic abnormalities has led to the widespread adoption of risk...
A series of somatic mutations...
07/23/2012
First Report Managed Care

Newsfeed

Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie
Interview
Reviewing the Benefits of a Treatment for Patients With Acute Myeloid Leukemia
08/09/2021
Julie Gould
Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie, discusses recent study findings presented at ASCO 2021, highlighting the efficacy of venetoclax for the treatment of acute myeloid leukemia.
Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie, discusses recent study findings presented at ASCO 2021, highlighting the efficacy of venetoclax for the treatment of acute myeloid leukemia.
Michael Werner, PhD, scientific...
08/09/2021
Population Health
News
New Guidelines Address for Care of Older Adults With AML
08/12/2020
The American Society of Hematology released new guidelines for treating older adults with acute myeloid leukemia, and recommends chemotherapy or other treatments over supportive care, along with more intensive therapy over less-intensive...
The American Society of Hematology released new guidelines for treating older adults with acute myeloid leukemia, and recommends chemotherapy or other treatments over supportive care, along with more intensive therapy over less-intensive...
The American Society of...
08/12/2020
First Report Managed Care
News
Substantial Economic Burden Accompanies Various AML Treatments
07/14/2020
“As data for this analysis were collected before approval for these new therapies, this study serves as a baseline for the clinical and economic burden associated with AML, allowing for comparisons related to the cost-benefit of emerging...
“As data for this analysis were collected before approval for these new therapies, this study serves as a baseline for the clinical and economic burden associated with AML, allowing for comparisons related to the cost-benefit of emerging...
“As data for this analysis were...
07/14/2020
First Report Managed Care
News
Palliative Care Proves Beneficial in Treatment of Patients With AML
06/03/2020
Patients with acute myeloid leukemia saw improvements in their quality of life when palliative care was integrated with their oncology treatment, according to recent data.
Patients with acute myeloid leukemia saw improvements in their quality of life when palliative care was integrated with their oncology treatment, according to recent data.
Patients with acute myeloid...
06/03/2020
First Report Managed Care
News
Examining Health Care Utilization, Clinical Burden of AML for Payers
05/07/2020
As the incidence rate of patients with AML in the US continues to rise, researchers of a recent study conducted an analysis of the economical and clinical burden of treatment for commercial payers.
As the incidence rate of patients with AML in the US continues to rise, researchers of a recent study conducted an analysis of the economical and clinical burden of treatment for commercial payers.
As the incidence rate of...
05/07/2020
First Report Managed Care
News
Myeloablative Conditioning Improves Survival Among Patients With AML
03/05/2020
Researchers recently found that myeloablative conditioning improved survival among patients with acute myeloid leukemia rather than reduced-intensity conditioning.
Researchers recently found that myeloablative conditioning improved survival among patients with acute myeloid leukemia rather than reduced-intensity conditioning.
Researchers recently found that...
03/05/2020
First Report Managed Care
News
Acute Myocardial Infarction Outcomes Worse in Patients With AML
01/31/2020
Compared with other patients, patients with leukemia were less likely to be offered coronary angiography and percutaneous coronary intervention following acute myocardial infarction, according to the study.
Compared with other patients, patients with leukemia were less likely to be offered coronary angiography and percutaneous coronary intervention following acute myocardial infarction, according to the study.
Compared with other patients,...
01/31/2020
First Report Managed Care
News
Lower Costs, Improved Survival Linked With Nonmyeloablative Conditioning for AML
01/15/2020
Nonmyeloablative conditioning was associated with lower reimbursement and improved overall survival 1 year after allogeneic hematopoietic cell transplantation in a group of older adults with acute myeloid leukemia, according to study findings.
Nonmyeloablative conditioning was associated with lower reimbursement and improved overall survival 1 year after allogeneic hematopoietic cell transplantation in a group of older adults with acute myeloid leukemia, according to study findings.
Nonmyeloablative conditioning...
01/15/2020
First Report Managed Care
Formulary Frontlines®
Exploring Treatment for Acute Myeloid Leukemia
06/18/2019

Edan Stanley

Edan Stanley
AML is the most common acute leukemia in adults with an estimated 21,450 new cases expected in 2019 in the United States and approximately 10,920 deaths. In this segment, we explore various treatments for AML.
AML is the most common acute leukemia in adults with an estimated 21,450 new cases expected in 2019 in the United States and approximately 10,920 deaths. In this segment, we explore various treatments for AML.
AML is the most common acute...
06/18/2019
First Report Managed Care
Formulary Frontlines®
Breakthroughs in Acute Myeloid Leukemia
10/26/2017

S Russell Spjut, PharmD, clinical pharmacist of formulary management at MagellanRx Management

S Russell Spjut, PharmD, clinical pha...
S Russell Spjut, PharmD, discusses current first-line therapies and new treatment opions used to treat acute myeloid leukemia and their associated costs. 
S Russell Spjut, PharmD, discusses current first-line therapies and new treatment opions used to treat acute myeloid leukemia and their associated costs. 
S Russell Spjut, PharmD,...
10/26/2017
First Report Managed Care
News
Keratoconus Appears to be Associated With Demodex Mites
05/16/2024
Jolynn Tumolo
Keratoconus, an eye disorder that leads to gradual curvature of the cornea, may be associated with Demodex infestation, suggests a small study published in the Oman Journal of Ophthalmology.
Keratoconus, an eye disorder that leads to gradual curvature of the cornea, may be associated with Demodex infestation, suggests a small study published in the Oman Journal of Ophthalmology.
Keratoconus, an eye disorder...
05/16/2024
First Report Managed Care
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs at AMCP
Interview
Unlocking the Future of Managed Care Pharmacy: A Deep Dive into Federal Legislation and Regulations
05/15/2024
Jennifer L. Mathieu Senior Vice President, Professional and Government Affairs, AMCP
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in federal legislation and regulations within the pharmacy landscape shaping the future of managed care in an interview with a session presenter from AMCP 2024.
Learn about developments in...
05/15/2024
First Report Managed Care
News
Hospital Costs May Be Higher for Patients With Private Insurance
05/14/2024
Hannah Musick
A recent research report reveals that individuals with private health insurance pay 254% more for hospital procedures than Medicare rates, leading to potentially increased costs for millions of Americans.
A recent research report reveals that individuals with private health insurance pay 254% more for hospital procedures than Medicare rates, leading to potentially increased costs for millions of Americans.
A recent research report reveals...
05/14/2024
First Report Managed Care
White Papers
Idiopathic Pulmonary Fibrosis (IPF): Existing Challenges and New Frontiers
05/13/2024

Reviewed by Elizabeth Volkmann, MD, MS

Reviewed by Elizabeth Volkmann, MD, M...
This white paper provides an overview of the IPF disease state and summarizes current unmet needs in treatment and management. Novel therapies in development have the potential to overcome treatment challenges and offer new hope for patients...
This white paper provides an overview of the IPF disease state and summarizes current unmet needs in treatment and management. Novel therapies in development have the potential to overcome treatment challenges and offer new hope for patients...
This white paper provides an...
05/13/2024
First Report Managed Care
IPF letters
Formulary Frontlines®
New Therapies in Development for Idiopathic Pulmonary Fibrosis (IPF) Address Existing Challenges With Diagnosis and Management
05/13/2024

Reviewed by Elizabeth Volkmann, MD, MS

Reviewed by Elizabeth Volkmann, MD, M...
IPF is a chronic, progressive interstitial lung disease that presents a significant burden to ~3 million patients worldwide. Despite ongoing challenges with IPF diagnosis and management, new therapies in development are showing promise.
IPF is a chronic, progressive interstitial lung disease that presents a significant burden to ~3 million patients worldwide. Despite ongoing challenges with IPF diagnosis and management, new therapies in development are showing promise.
IPF is a chronic, progressive...
05/13/2024
First Report Managed Care
News
Study Finds No Treatment-Related Adverse Events in Boys Treated With Purified FIX Concentrate
05/09/2024
Jolynn Tumolo
Purified factor IX (FIX) concentrate was effective in treating and preventing bleeding episodes in real-world pediatric patients 6 years and younger with hemophilia B, according to a study published in the Journal of Blood Medicine.
Purified factor IX (FIX) concentrate was effective in treating and preventing bleeding episodes in real-world pediatric patients 6 years and younger with hemophilia B, according to a study published in the Journal of Blood Medicine.
Purified factor IX (FIX)...
05/09/2024
First Report Managed Care
News
Demodex Infestation Found in 9 of 10 Eye Clinic Patients Using 2-Minute Technique
05/09/2024
Jolynn Tumolo
Demodex mites were found in the eyelashes of 94% of patients examined with a simple diagnostic technique at a standard ophthalmic practice, according to a study published online in the journal Clinical Ophthalmology.
Demodex mites were found in the eyelashes of 94% of patients examined with a simple diagnostic technique at a standard ophthalmic practice, according to a study published online in the journal Clinical Ophthalmology.
Demodex mites were found in the...
05/09/2024
First Report Managed Care
Luke Greenwalt
Insights into the 2024 Payer Landscape: Enhancing Patient Care Opportunities
05/07/2024

Featuring Luke Greenwalt, Vice President, Market Access, IQVIA

Featuring Luke Greenwalt, Vice Presid...
Guest speaker from the Asembia AXS24 summit emphasizes the need for early payer involvement in drug development and highlights the challenges and complexities surrounding drug coverage in an interview with First Report Managed Care. Luke...
Guest speaker from the Asembia AXS24 summit emphasizes the need for early payer involvement in drug development and highlights the challenges and complexities surrounding drug coverage in an interview with First Report Managed Care. Luke...
Guest speaker from the Asembia...
05/07/2024
First Report Managed Care
Jay Ackerman Headshot
Interview
AI's Impact on Value-Based Care Outcomes
05/07/2024
Jay Ackerman, President & CEO, Reveleer
Artificial intelligence (AI)-powered workflows and prospective analytics are advancing value-based care by improving patient outcomes and reducing costs. In a recent interview, an expert emphasizes that leveraging AI technologies enables...
Artificial intelligence (AI)-powered workflows and prospective analytics are advancing value-based care by improving patient outcomes and reducing costs. In a recent interview, an expert emphasizes that leveraging AI technologies enables...
Artificial intelligence...
05/07/2024
First Report Managed Care
Anne Headshot
Commentary
Long-Term, High-Impact Nursing Care Solutions Promote High-Value Care
05/06/2024
Anne Dabrow Woods, DNP, RN, CRNP, ANP-BC, AGACNP-BC, FAAN
It's no secret that nursing is in a state of crisis. From the onset of the COVID-19 pandemic to now, nurses nationwide have increasingly battled rising burnout and stress–all while caring for higher-acuity patients, with less support. Anne...
It's no secret that nursing is in a state of crisis. From the onset of the COVID-19 pandemic to now, nurses nationwide have increasingly battled rising burnout and stress–all while caring for higher-acuity patients, with less support. Anne...
It's no secret that nursing is...
05/06/2024
First Report Managed Care

Advertisement

Insights

Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie
Interview
Reviewing the Benefits of a Treatment for Patients With Acute Myeloid Leukemia
08/09/2021
Julie Gould
Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie, discusses recent study findings presented at ASCO 2021, highlighting the efficacy of venetoclax for the treatment of acute myeloid leukemia.
Michael Werner, PhD, scientific director of oncology for US medical affairs, AbbVie, discusses recent study findings presented at ASCO 2021, highlighting the efficacy of venetoclax for the treatment of acute myeloid leukemia.
Michael Werner, PhD, scientific...
08/09/2021
Population Health

Advertisement

Advertisement

Advertisement

FRMC Volume 21, Issue 1

Current Issue

March 2024
Volume 21
Issue 1
Current Issue
Issue Archive

Advertisement

What's Trending?

News
CMS Issues Rules on Loss Ratios for Medicare Plans
02/19/2013
02/19/2013
First Report Managed Care
News
Why Are Some Patients Still Paying for HIV Preventive Care?
03/04/2022

Sarah Varney, Kaiser Health News 

Sarah Varney, Kaiser Health News  ...
As of January 2021, HIV preventive care was supposed to be free in the United States, but there are patients still paying for treatment.
As of January 2021, HIV preventive care was supposed to be free in the United States, but there are patients still paying for treatment.
As of January 2021, HIV...
03/04/2022
First Report Managed Care
Gould and Henry
Interview
Understanding the Implications of Medicare Advantage Growth
11/30/2023

Featuring Michael Gould, Associate Vice President of Interoperability Strategy at ZeOmega, and Cindy Henry, PMP, Director of Population Health Informatics at ZeOmega 

Featuring Michael Gould, Associate Vi...
Learn about the growth of Medicare Advantage and its impact on the health care industry. Michael Gould and Cindy Henry discuss the popularity of Medicare Advantage plans, the potential effects of new regulations, and the importance of strong...
Learn about the growth of Medicare Advantage and its impact on the health care industry. Michael Gould and Cindy Henry discuss the popularity of Medicare Advantage plans, the potential effects of new regulations, and the importance of strong...
Learn about the growth of...
11/30/2023
First Report Managed Care
News
Doctors limit new Medicare patients
06/21/2010
06/21/2010
First Report Managed Care
Dr Brian Covino
Interview
Green Lighting Solutions to Address Barriers in Health Care Prior Authorizations
03/05/2024

Featuring Brian Covino, MD, CMO, Cohere Health

Featuring Brian Covino, MD, CMO, Cohe...
There are several barriers to adopting electronic prior authorization in health care. With financial incentives and standardized processes, there is still room for improvement. An expert introduces the concept of green lighting, a data-driven...
There are several barriers to adopting electronic prior authorization in health care. With financial incentives and standardized processes, there is still room for improvement. An expert introduces the concept of green lighting, a data-driven...
There are several barriers to...
03/05/2024
First Report Managed Care

Video Insights

Tejaswi Kompala
Videos
Personalizing Weight Loss Management With GLP-1 Agonists
04/05/2024

Featuring Tejaswi Kompala, MD, head of cardiometabolic clinical strategy, Teladoc 

Featuring Tejaswi Kompala, MD, head o...
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for anti-obesity medications, the complexities of obesity management, and the importance of personalized approaches in improving cardiometabolic health in this insightful interview.
Delve into the rising demand for...
04/05/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Substance Use Disorder and Social Determinants of Health
03/27/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of an engaging two-part series showcasing an expert dedicated to reducing emergency department visits through the integration of behavioral health practices. Dr Zaubler will share invaluable insights into...
Join us for the continuation of...
03/27/2024
First Report Managed Care
Zaubler Headshot
Videos
Integrating Behavioral Health Services to Reduce ED Visits: Suicide Prevention and Preemptive Primary Care
03/25/2024

Featuring Tom Zaubler, MD, MPH, CMO at NeuroFlow

Featuring Tom Zaubler, MD, MPH, CMO a...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first installment of a captivating two-part series featuring an expert committed to minimizing emergency department visits through the implementation of behavioral health integrations. Dr Zaubler will offer valuable...
Come join us for the first...
03/25/2024
First Report Managed Care
Yash Prajapati
Videos
Navigating the Evolution of Digital Solutions in Health Care
02/27/2024

Featuring Yash Prajapati, consultant at ZS Associates 

Featuring Yash Prajapati, consultant ...
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the challenges and opportunities in the development, approval, and integration of digital therapeutic solutions with ZS Associates consultant Yash Prajapati.
Join us in exploring the...
02/27/2024
First Report Managed Care
Mansur Shomali
Videos
Advancements and Challenges in Diabetes Management
02/27/2024

Featuring Mansur Shomali, MD, chief medical officer at Welldoc, endocrinologist at MedStar Health 

Featuring Mansur Shomali, MD, chief m...
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital therapeutics for disease management such as diabetes care in terms of cost, outcomes, integration, and more with Dr Mansur Shomali, CMO at Welldoc.
Learn about the state of digital...
02/27/2024
First Report Managed Care
kevin cowart md
Videos
Costs and Benefits: How a New Cholesterol-Lowering Drug Compares to Others
10/24/2023

Featuring Kevin Cowart, PharmD, MPH, BCACP, CDCES

Featuring Kevin Cowart, PharmD, MPH, ...
Dr Kevin Cowart, assistant professor at the University of South Florida College of Pharmacy, discusses inclisiran, a new non-statin treatment for high cholesterol.
Dr Kevin Cowart, assistant professor at the University of South Florida College of Pharmacy, discusses inclisiran, a new non-statin treatment for high cholesterol.
Dr Kevin Cowart, assistant...
10/24/2023
First Report Managed Care
John Hennessy Headshot
Videos
Biosimilars, Explained
10/24/2023

Featuring John Hennessey, MBA

Featuring John Hennessey, MBA
In this video, John Hennessey, MBA, Valuate Health Consultancy, explains biosimilars in relation to cancer care: what they are, why they matter, and how they have and haven’t lived up to their promise.
In this video, John Hennessey, MBA, Valuate Health Consultancy, explains biosimilars in relation to cancer care: what they are, why they matter, and how they have and haven’t lived up to their promise.
In this video, John Hennessey,...
10/24/2023
First Report Managed Care
Videos
AVAHO 2023: Andrew Brunner, MD, Discusses Updates in MDS
10/20/2023

Featuring Andrew Brunner, MD

Featuring Andrew Brunner, MD
In this video, Dr Brunner reviews his recent discussion he held at the 2023 AVAHO Annual Meeting, and provides treatment updates in the treatment of MDS.
In this video, Dr Brunner reviews his recent discussion he held at the 2023 AVAHO Annual Meeting, and provides treatment updates in the treatment of MDS.
In this video, Dr Brunner...
10/20/2023
First Report Managed Care
Dr Kesty Headshot
Videos
A Dermatologist's Perspective on Demodex Blepharitis: Causes, Symptoms, and Treatment Options
10/19/2023

Featuring Katarina Kesty, MD, MBA, FAAD, Dermatologist and Medical Director at St. Petersburg Skin and Laser

Featuring Katarina Kesty, MD, MBA, FA...
Katarina Kesty, MD, MBA, FAAD, Dermatologist and Medical Director at St. Petersburg Skin and Laser, weighs in on Demodex blepharitis, a condition characterized by inflammation of the eyelid margin caused by an overpopulation of Demodex mites,...
Katarina Kesty, MD, MBA, FAAD, Dermatologist and Medical Director at St. Petersburg Skin and Laser, weighs in on Demodex blepharitis, a condition characterized by inflammation of the eyelid margin caused by an overpopulation of Demodex mites,...
Katarina Kesty, MD, MBA, FAAD,...
10/19/2023
First Report Managed Care

Subscribe to our eNewsletters!

First Report Managed Care Newsletter

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use

Advertisement

Advertisement